Skip to main content
Clinical Trials/CTRI/2022/01/039180
CTRI/2022/01/039180
Completed
Phase 2

A randomized, controlled clinical study to compare efficacy of a polyherbal formulation (GP/PROD/2021/004) versus Standard Allopathic Formulation for relief of acutenonproductive cough and throat irritation - Nil

Mr Kamlesh Thummar0 sites66 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Completed
Sponsor
Mr Kamlesh Thummar
Enrollment
66

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with H/O acute nonproductive cough and throat irritation for less than 1week duration
  • Males and Females between 18\-65 years age
  • Patients who in the opinion of the Investigator will be able to comply with the study requirements
  • Patients with a cough score of 0, 1 or 2 during day time
  • Patients willing and able to provide signed informed consent for any study related procedures.

Exclusion Criteria

  • Patients with H/O lower respiratory tract infections such as Pneumonia, Tuberculosis, Bronchitis, Whooping cough.
  • Patients with H/O Chronic Obstructive Pulmonary
  • Diseases/Asthma
  • Patients with H/O underlying lung pathology such as lung abscess, cystic fibrosis.
  • Patients with known hypersensitivity to ingredients of Investigational Products
  • Patients with clinical suspicion of any systemic bacterial infection.
  • Patients with H/O Myocardial Infarction (MI) within 4 weeks prior to enrollment
  • Patients with immediate life threatening diseases such as pre\-existing cardiovascular, liver or neoplastic disease.

Investigators

Sponsor
Mr Kamlesh Thummar

Similar Trials